Pfizer Inc. (PFE) has agreed to pay $3.3 million to Oregon to settle an investigation into whether Pfizer deceptively marketed the antibiotic Zyvox, according to the Oregon Attorney General's office.
The Oregon Department of Justice conducted a two-year investigation of claims that New York-based Pfizer relied upon flawed clinical trials to assert that Zyvox was superior to a generic drug, vancomycin.
Pfizer's sales representatives distributed thousands of copies of allegedly faulty studies throughout Oregon to promote the sale of Zyvox, the Oregon Attorney General's office said in a press release Tuesday. Zyvox is approved to treat certain bacterial infections including pneumonia.
Pfizer said in a written statement it denied any wrongdoing, and said the settlement avoids further time and cost of litigation. Pfizer said it is committed to providing doctors and the public with science-based information about its medicines.
Pfizer's payment of $3.3 million will reimburse state government health programs for purchases of Zyvox, and fund a new program teaching consumers about proper use of antibiotics.
Wednesday, March 21, 2012
Pfizer To Pay $3.3M To Oregon To Settle Zyvox Probe | Fox Business